| Literature DB >> 30968303 |
Adel Shalata1,2,3, Michael Edery4, Clair Habib5,6, Jacob Genizi6,7,8, Mohammad Mahroum5,9, Lama Khalaily5, Nurit Assaf6,7,8, Idan Segal6,7, Hoda Abed El Rahim10,11, Hana Shapira5, Danielle Urian10, Shay Tzur12,13, Liza Douiev4,14, Ann Saada15,16.
Abstract
Primary deficiency of coenzyme Q10 (CoQ10 ubiquinone), is classified as a mitochondrial respiratory chain disorder with phenotypic variability. The clinical manifestation may involve one or multiple tissue with variable severity and presentation may range from infancy to late onset. ADCK3 gene mutations are responsible for the most frequent form of hereditary CoQ10 deficiency (Q10 deficiency-4 OMIM #612016) which is mainly associated with autosomal recessive spinocerebellar ataxia (ARCA2, SCAR9). Here we provide the clinical, biochemical and genetic investigation for unrelated three nuclear families presenting an autosomal form of Spino-Cerebellar Ataxia due to novel mutations in the ADCK3 gene. Using next generation sequence technology we identified a homozygous Gln343Ter mutation in one family with severe, early onset of the disease and compound heterozygous mutations of Gln343Ter and Ser608Phe in two other families with variable manifestations. Biochemical investigation in fibroblasts showed decreased activity of the CoQ dependent mitochondrial respiratory chain enzyme succinate cytochrome c reductase (complex II + III). Exogenous CoQ slightly improved enzymatic activity, ATP production and decreased oxygen free radicals in some of the patient's cells. Our results are presented in comparison to previously reported mutations and expanding the clinical, molecular and biochemical spectrum of ADCK3 related CoQ10 deficiencies.Entities:
Keywords: ADCK3; Coenzyme Q; Mitochondrial disease; Q10 deficiency-4; SCAR9; Spinocerebellar ataxia
Mesh:
Substances:
Year: 2019 PMID: 30968303 DOI: 10.1007/s11064-019-02786-5
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996